Projects per year
- 1 - 50 out of 128 results
Search results
-
Active
A Phase 2, Randomized, Double-Blind, Active-Controlled, Dose-Finding Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of VAX-31 in Healthy Infants Given 4 Doses at 2, 4, 6, and 12-15 Months of Age Concomitantly with Routine Pediatr
Rupp, R. (PI)
3/11/25 → 3/10/30
Project: Research project
-
Teen Health Award 2025-2027
Rupp, R. (PI)
Sealy and Smith Foundation ( Award # )
1/1/25 → 12/31/27
Project: Research project
-
A MULTICENTER, OPEN-LABEL, PHASE 1B STUDY TO ASSESS THE PHARMACOKINETICS, SAFETY, AND TOLERABILITY OF SULBACTAM-DURLOBACTAM IN HOSPITALIZED PEDIATRIC PATIENTS FROM BIRTH TO <18 YEARS WHO ARE RECEIVING SYSTEMIC ANTIBIOTIC THERAPY FOR SUSPECTED OR CONFIRM
Aigbivbalu, L. (PI)
Entasis Therapeutics ( Award # )
12/23/24 → 12/22/29
Project: Research project
-
A Randomized, Double-Blind Study to Evaluate the Safety, Tolerability, and Immunogenicity of V118 Formulation C in Healthy Adults
Rupp, R. (PI)
Merck Sharp and Cohme Corporation ( Award # )
8/27/24 → 8/26/28
Project: Research project
-
A Phase 3, randomized, modified double-blind, active-controlled, parallel-group, 4-arm study to investigate the mixed vaccination schedules of a 21-valent pneumococcal conjugate vaccine and a 20-valent pneumococcal conjugate vaccine in healthy infants an
Rupp, R. (PI)
Sanofi Pasteur, Inc ( Award # )
7/19/24 → 7/18/29
Project: Research project
-
Protein Cargo and Antiviral Properties of Epithelial-derived EVs in RSV Infection
Corsello, T. (PI)
Parker B. Francis Fellowship Program ( Award # )
7/1/24 → 6/30/27
Project: Research project
-
EPAC1 as a Crucial Host Factor and Therapeutic Target of SARS-CoV-2
Bao, X. (PI)
American Lung Association - National ( Award #ERP-1252718)
7/1/24 → 6/30/26
Project: Research project
-
Extracellular Vesicles (EVs) Innate Immune Cargo in Respiratory Viral Infections
Garofalo, R. P. (PI)
National Institute of Allergy and Infectious Diseases ( Award #1R21AI17608501A1)
6/18/24 → 4/30/26
Project: Research project
-
Pilot DSHS Newborn Screening
Cooney, E. (PI)
Texas Department of State Health Services ( Award #HHS001417100002)
6/17/24 → 8/31/28
Project: Research project
-
Phase III, randomized, single-blind, placebo-controlled, multi-center study to evaluate non-interference of concomitant administration of routine pediatric vaccines on the antibody response of an investigational live-attenuated respiratory syncytial viru
Rupp, R. (PI)
Sanofi Pasteur, Inc ( Award # )
5/8/24 → 5/7/29
Project: Research project
-
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Safety and Immunogenicity of V181 Dengue Quadrivalent Vaccine rDENV30 live, attenuated in Healthy Adults 59 Years of Age or Older
Rupp, R. (PI)
Merck Sharp and Cohme Corporation ( Award # )
10/17/23 → 10/16/28
Project: Research project
-
DMID Program Planning Agreement - Next Generation Covid-19 Vaccine Development Program
Rupp, R. (PI)
Leidos Biomedical Research, Inc ( Award #75N91019D00024)
8/18/23 → 12/31/25
Project: Research project
-
Role of Airway Derived Extracellular Vesicles (EVs) in Respiratory Viral Infections
Corsello, T. (PI)
American Lung Association - National ( Award #CA1040556)
7/1/23 → 12/31/25
Project: Research project
-
A Randomized, Double-Blind Study to Evaluate the Safety, Tolerability, and Immunogenicity of V117 Formulation C in Healthy Adults
Rupp, R. (PI)
Merck Sharp and Cohme Corporation ( Award # )
6/28/23 → 6/27/28
Project: Research project
-
Role of Hypoxia-Inducible Factors (HIFs) in Respiratory Syncytial Virus Infection
Casola, A. (PI)
National Institute of Allergy and Infectious Diseases ( Award #5R21AI17595502)
6/16/23 → 8/31/25
Project: Research project
-
tRNA-derived RNA Fragments (tRF) as Prognostic and Diagnostic Biomarkers for Alzheimer¿s Disease
Bao, X. (PI)
National Institute on Aging ( Award #5R61AG07572503)
3/15/23 → 2/28/26
Project: Research project
-
PIWIL4 and piRNAs in RSV Infection
Casola, A. (PI)
National Institute of Allergy and Infectious Diseases ( Award #5R21AI17166402)
1/25/23 → 8/31/25
Project: Research project
-
Biogenesis and Function of tRNA-derived RNA Fragments in Alzheimer's Disease: Novel Biomarkers
Bao, X. (PI)
Darrell K. Royal Research Fund for Alzheimer's Disease ( Award # )
9/1/22 → 8/31/26
Project: Research project
-
A Phase 1/2a Open-Label Dose-Ranging and Observer-Blind Placebo-Controlled, Safety and Immunogenicity Study of mRNA-1647 Cytomegalovirus Vaccine in Female and Male Participants 9 to 15 Years of Age and Participants 16 to 25 Years of Age
Rupp, R. (PI)
Moderna Therapeutics, Inc ( Award # )
8/30/22 → 8/29/27
Project: Research project
-
tRNA-derived RNA Fragments and their Role in Nasal SARS-COVID-2 Infection
Bao, X. (PI)
National Institute of Allergy and Infectious Diseases ( Award #5R21AI16654302)
7/1/22 → 6/30/26
Project: Research project
-
A Phase 1/2, First-Time-in Human (FTiH), randomized, observer-blind, placebo-controlled, dose escalation study to assess safety, reactogenicity and immunogenicity of a candidate cytomegalovirus (CMV) vaccine comprising recombinant protein and adjuvant wh
Rupp, R. (PI)
GlaxoSmithKline Pharmaceuticals ( Award # )
11/12/21 → 11/11/26
Project: Research project
-
A Phase 3, Multicenter, Open-Label Study to Evaluate the Safety and Immunogenicity of 2-dose Regimens of 9vHPV and mRNA1273 SARS-CoV-2 Vaccines Where the First Dose of Each Vaccine Are Given Concomitantly in Boys and Girls 9 to 11 Years of Age
Rupp, R. (PI)
Merck Sharp and Cohme Corporation ( Award # )
10/19/21 → 10/18/26
Project: Research project
-
PHASE 1, OPEN-LABEL DOSE-FINDING STUDY TO EVALUATE SAFETY, TOLERABILITY, AND IMMUNOGENICITY AND PHASE 2/3 PLACEBO-CONTROLLED, OBSERVER-BLINDED SAFETY, TOLERABILITY, AND IMMUNOGENICITY STUDY OF A SARS-COV-2 RNA VACCINE CANDIDATE AGAINST COVID-19 IN HEALTH
Rupp, R. (PI)
3/29/21 → 3/28/26
Project: Research project
-
A Phase 3 International, Multicenter, Open-label Study to Evaluate the Safety and Immunogenicity of 9vHPV Vaccine Administered as 2-dose Regimen with Extended Dosing Intervals in 9- to 14-Year Old Boys and Girls Compared with a Standard 3-dose Regimen
Rupp, R. (PI)
Merck Sharp and Cohme Corporation ( Award # )
12/22/20 → 12/21/25
Project: Research project
-
A Phase 3, International, Multi-center, Randomized, Double-blind, Placebo- controlled Clinical Trial to Study the Efficacy, Immunogenicity, and Safety of the 9vHPV Vaccine, a Multivalent L1 Virus-like Particle Vaccine, in the prevention of oral persistencvbcvbcvbcvbcvbcvbcbcbcbcb
Rupp, R. (PI)
Merck Sharp and Cohme Corporation ( Award # )
12/12/19 → 12/11/26
Project: Research project
-
Admin Core
Garofalo, R. P. (PI)
National Institute of Allergy and Infectious Diseases ( Award #5P01AI06288515)
7/25/18 → 6/30/25
Project: Research project
-
Completed
-
Translational studies of the fecal microbiome associated with BIAFAC
Pyles, R. (PI)
Glenn Greenberg and Linda Vester Foundation ( Award # )
1/1/22 → 12/31/24
Project: Research project
-
A Phase 1/2 Study of Delayed Heterologous SARS-CoV-2 Vaccine Dosing (Boost) after Receipt of EUA Vaccines
Rupp, R. (PI)
Baylor College of Medicine ( Award #3UM1AI14857503S2)
7/14/21 → 11/30/24
Project: Research project
-
IMPAACT Leadership Group-PTCL 03
Rupp, R. (PI)
Johns Hopkins University ( Award #5UM1AI06863217)
12/1/20 → 11/30/23
Project: Research project
-
Innate Inhibitory Activity and Anti-SARS-CoV-2 Antibodies in Human Milk
Garofalo, R. P. (PI)
11/20/20 → 11/19/23
Project: Research project
-
tRNA-derived RNA Fragments, A New Regulator for Alzheimer's Disease
Bao, X. (PI)
National Institute on Aging ( Award #5R21AG06922601)
9/15/20 → 8/31/24
Project: Research project
-
Vaccine and Treatment Evaluation Units (VTEU)- COVID Supplement
Rupp, R. (PI)
Baylor College of Medicine ( Award #3UM1AI14857503S6)
7/13/20 → 11/30/23
Project: Research project